125 related articles for article (PubMed ID: 3146501)
1. Factors attenuating growth promoting effect of growth hormone therapy for Turner's syndrome.
Sato T; Miyamori C; Kajiwara S; Miyagawa K; Shimizu M
Endocrinol Jpn; 1988 Oct; 35(5):725-31. PubMed ID: 3146501
[TBL] [Abstract][Full Text] [Related]
2. Treatment of 94 patients with Turner's syndrome with recombinant human growth hormone (SM-9500) for two years--the results of a multicentric study in Japan. Committee for the Treatment of Turner's Syndrome.
Takano K; Shizume K; Hibi I
Endocrinol Jpn; 1989 Aug; 36(4):569-78. PubMed ID: 2684622
[TBL] [Abstract][Full Text] [Related]
3. Treatment of 80 patients with Turner's syndrome with recombinant human growth hormone (YM-17798) for one year: the results of a multicentric study in Japan. Committee for the Treatment of Turner's Syndrome.
Takano K; Shizume K; Hibi I
Endocrinol Jpn; 1989 Apr; 36(2):253-60. PubMed ID: 2673750
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Turner's syndrome with methionyl human growth hormone for six months.
Takano K; Hizuka N; Shizume K
Acta Endocrinol (Copenh); 1986 May; 112(1):130-7. PubMed ID: 3521183
[TBL] [Abstract][Full Text] [Related]
5. Turner's syndrome: treatment of 203 patients with recombinant human growth hormone for one year. A multicentre study.
Takano K; Shizume K; Hibi I
Acta Endocrinol (Copenh); 1989 May; 120(5):559-68. PubMed ID: 2658450
[TBL] [Abstract][Full Text] [Related]
6. Plasma growth hormone-binding protein activity, insulin-like growth factor I, and its binding protein levels in patients with Turner's syndrome: effect of short- and long-term recombinant human growth hormone administration.
Saggese G; Federico G; Cinquanta L
Pediatr Res; 1995 Jan; 37(1):106-11. PubMed ID: 7535419
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone treatment in Turner's syndrome.
Takano K; Hizuka N; Shizume K
Acta Paediatr Scand Suppl; 1986; 325():58-63. PubMed ID: 3473892
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone treatment in Turner's syndrome: short and long-term effects on metabolic parameters.
Haeusler G; Frisch H
Clin Endocrinol (Oxf); 1992 Mar; 36(3):247-53. PubMed ID: 1563078
[TBL] [Abstract][Full Text] [Related]
9. Glucose turnover and insulin clearance after growth hormone treatment in girls with Turner's syndrome.
Monti LD; Brambilla P; Caumo A; Magni F; Omati S; Nizzoli G; di Natale B; Galli-Kienle M; Cobelli C; Chiumello G; Pozza G
Metabolism; 1997 Dec; 46(12):1482-8. PubMed ID: 9439548
[TBL] [Abstract][Full Text] [Related]
10. Growth response in Turner syndrome with recombinant human growth hormone therapy.
Tuchinda C; Angsusingha K; Punnakanta L; Likitmaskul S; Wacharasindhu S; Tuanakitcharu K; Pitukcheewanont P
Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():142-5. PubMed ID: 8629094
[TBL] [Abstract][Full Text] [Related]
11. Twenty-four hour plasma GH, FSH and LH profiles in patients with Turner's syndrome.
Villadolid MC; Takano K; Hizuka N; Asakawa K; Sukegawa I; Horikawa R; Shizume K
Endocrinol Jpn; 1988 Feb; 35(1):71-81. PubMed ID: 3135180
[TBL] [Abstract][Full Text] [Related]
12. Influence of spontaneous or induced puberty on the growth promoting effect of treatment with growth hormone in girls with Turner's syndrome.
Massa G; Maes M; Heinrichs C; Vandeweghe M; Craen M; Vanderschueren-Lodeweyckx M
Clin Endocrinol (Oxf); 1993 Mar; 38(3):253-60. PubMed ID: 8458097
[TBL] [Abstract][Full Text] [Related]
13. Specific, time-dependent actions of low-dose ethinyl estradiol administration on the episodic release of growth hormone, follicle-stimulating hormone, and luteinizing hormone in prepubertal girls with Turner's syndrome.
Mauras N; Rogol AD; Veldhuis JD
J Clin Endocrinol Metab; 1989 Nov; 69(5):1053-8. PubMed ID: 2507569
[TBL] [Abstract][Full Text] [Related]
14. Evidence for dopaminergic stimulation of growth velocity in some hypopituitary children.
Huseman CA; Hassing JM
J Clin Endocrinol Metab; 1984 Mar; 58(3):419-25. PubMed ID: 6420440
[TBL] [Abstract][Full Text] [Related]
15. Effects of acute high dose and chronic low dose estrogen on plasma somatomedin-C and growth in patients with Turner's syndrome.
Copeland KC
J Clin Endocrinol Metab; 1988 Jun; 66(6):1278-82. PubMed ID: 3372687
[TBL] [Abstract][Full Text] [Related]
16. Growth-promoting effect of growth hormone and low dose ethinyl estradiol in girls with Turner's syndrome.
Vanderschueren-Lodeweyckx M; Massa G; Maes M; Craen M; van Vliet G; Heinrichs C; Malvaux P
J Clin Endocrinol Metab; 1990 Jan; 70(1):122-6. PubMed ID: 2294126
[TBL] [Abstract][Full Text] [Related]
17. Treatment of 46 patients with Turner's syndrome with recombinant human growth hormone (YM-17798) for three years: a multicentre study.
Takano K; Shizume K; Hibi I
Acta Endocrinol (Copenh); 1992 Apr; 126(4):296-302. PubMed ID: 1595324
[TBL] [Abstract][Full Text] [Related]
18. Hepatic adenoma associated with recombinant human growth hormone therapy in a patient with Turner's syndrome.
Espat J; Chamberlain RS; Sklar C; Blumgart LH
Dig Surg; 2000; 17(6):640-643. PubMed ID: 11155014
[TBL] [Abstract][Full Text] [Related]
19. [Stimulation test of the adenohypophysis with arginine, gonadotropin-releasing hormone (GRH), and thyrotropin-releasing hormone (TRH) in 45, XO patients with Turner's syndrome (author's transl)].
Rudolf K; Kyank H; Göretzlehner G; Kunkel S
Arch Gynecol; 1980; 229(2):155-60. PubMed ID: 6768344
[TBL] [Abstract][Full Text] [Related]
20. Growth-stimulating effects of human growth hormone therapy in patients with Turner syndrome.
Raiti S; Moore WV; Van Vliet G; Kaplan SL
J Pediatr; 1986 Dec; 109(6):944-9. PubMed ID: 3537250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
